Corporate ActionJun 3, 2026, 08:20 AM
NRx Pharmaceuticals Prices $20M Public Offering of 5.7M Shares
AI Summary
NRx Pharmaceuticals, Inc. announced the pricing of an underwritten public offering of 5,714,286 shares of its common stock at $3.50 per share. This offering is expected to generate gross proceeds of approximately $20.0 million. The company has also granted underwriters a 30-day option to purchase an additional 857,142 shares, potentially increasing gross proceeds to $23.0 million. The offering is anticipated to close on June 4, 2026, with net proceeds intended for working capital and general corporate purposes to support growth.
Key Highlights
- NRx Pharmaceuticals priced an underwritten public offering of 5,714,286 shares of common stock.
- The offering price is set at $3.50 per share.
- Gross proceeds are expected to be approximately $20.0 million.
- Underwriters have a 30-day option to purchase an additional 857,142 shares.
- If the option is fully exercised, gross proceeds could reach $23.0 million.
- The offering is expected to close on June 4, 2026.
- Net proceeds will be used for working capital and general corporate purposes.
Price Impact
More from NRXP